Eckert & Ziegler will be admitted to the MSCI Germany Small Cap Index
DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Miscellaneous
Berlin, 14 May 2019. Berlin-based Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), a specialist in isotope-related applications in medicine, science and industry will be admitted to the MSCI Germany Small Cap Index as of 28 May 2019. This decision was announced by MSCI Inc., a leading provider of research-based indexes, after its semi-annual index review for the MSCI equity indexes. In addition to the high transparency requirements of the Prime Standard, the Eckert & Ziegler shares thereby also fulfill the relevant index criteria such as market capitalization, momentum and yield.
"The strong increase in the value of the share over the past few quarters has confirmed our strategy to focus Eckert & Ziegler more on innovative pharmaceuticals for cancer treatment",
The MSCI Germany Small Cap Index currently is composed by 113 companies of the German equity market.
14.05.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
|Company:||Eckert & Ziegler Strahlen- und Medizintechnik AG|
|Phone:||49 30 941084-138|
|Fax:||49 30 941084-112|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange|
|EQS News ID:||811157|
|End of News||DGAP News Service|